# Comparative efficacy and safety of Chinese botanical drug injection in patients with sepsis: A systematic review and Bayesian network meta-analysis of randomized clinical trials

**Authors:** Yue Yuan, Jiajia Wang, Siyuan Lei, Jiansheng Li

PMC · DOI: 10.1371/journal.pone.0343026 · PLOS One · 2026-03-24

## TL;DR

This study compares Chinese botanical drug injections combined with Western treatments for sepsis, finding some combinations more effective in improving patient outcomes.

## Contribution

A Bayesian network meta-analysis identifies specific Chinese botanical drug injections that show superior efficacy in sepsis treatment when combined with Western medicine.

## Key findings

- Huangqi injection improves APACHE II scores most effectively.
- Xuebijing injection lowers white blood cell counts best.
- Shenmai injection reduces C-reactive protein and TNF-alpha levels most effectively.

## Abstract

Sepsis represents a significant global health challenge, contributing to considerable morbidity, mortality, and healthcare costs. Integrating Chinese botanical drug injections (CBDIs) with Western Medical Treatments (WMT) has been increasingly recognized for its enhanced therapeutic effects in sepsis management. This Bayesian network meta-analysis aims to identify the optimal combination regimen of CBDIs and WMT for sepsis therapy.

A comprehensive literature search was conducted across eight electronic databases to identify Randomized Controlled Trials (RCTs) relevant to our study criteria, spanning from their inception until January 1, 2024. The quality of included studies was rigorously assessed using the Cochrane Collaboration's Risk of Bias 2 (ROB 2) tool. Data synthesis and analysis were performed utilizing R 4.1.2 and Stata 17.0 software. Additionally, publication bias was assessed through the construction of funnel plots.

This network meta-analysis assessed 72 RCTs involving 6,351 participants to evaluate the effectiveness of seven CBDIs in conjunction with WMT. It found Huangqi injection to be the most effective in improving APACHE II scores. Tanreqing injections significantly reduced procalcitonin (PCT) levels, with particularly superior. Shenmai injection was most effective in decreasing C-reactive protein (CRP) levels. In terms of reducing tumor necrosis factor-alpha (TNF-α), Shenmai injection with WMT showed the best results. Xuebijing injection stood out in lowering white blood cell counts (WBC). Huangqi injection was noted for its best effectiveness in the 28-day mortality rates.

The therapeutic efficacy of CBDIs in treating sepsis is underscored by our research findings, wherein certain botanical drugs exhibit heightened efficacy and safety attributes. The incorporation of these alternative modalities into contemporary sepsis management paradigms is advocated by the outcomes of our investigation. Nonetheless, rigorous, large-scale trials are imperative to substantiate and enhance these preliminary discoveries.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** multi-organ dysfunction (MESH:D009102), shock (MESH:D012769), infection (MESH:D007239), septic shock (MESH:D012772), trauma (MESH:D014947), Sepsis (MESH:D018805), Cancer (MESH:D009369), endothelial injury (MESH:D057772), deaths (MESH:D003643), bacterial infection (MESH:D001424), immune dysregulation (OMIM:614878), critically ill (MESH:D016638), WMT (MESH:D020241), infectious diseases (MESH:D003141), toxicity (MESH:D064420), CBDIs (MESH:C562377), SIRS (MESH:D018746), fatigue (MESH:D005221), inflammation (MESH:D007249), allergies (MESH:D004342)
- **Chemicals:** SM (MESH:D012493), HQ (-), astragaloside IV (MESH:C052064), lactate (MESH:D019344), baicalin (MESH:C038044)
- **Species:** Schisandra (genus) [taxon 13673], Ophiopogon (genus) [taxon 100502], Homo sapiens (human, species) [taxon 9606], Panax ginseng (Asiatic ginseng, species) [taxon 4054]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012499/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012499/full.md

## References

107 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012499/full.md

---
Source: https://tomesphere.com/paper/PMC13012499